CombiMatrix, a CLIA-certified laboratory, is bringing microarray analysis to the underserved problem of recurrent pregnancy loss as well as to prenatal testing. CombiMatrix performs microarray ...

Purpose: Chromosomal microarray (CMA) testing provides the highest diagnostic yield for clinical testing of patients with developmental delay (DD), intellectual disability (ID), multiple ...

A large, multi-center clinical trial led by researchers from Columbia University Medical Center shows that a new genetic test resulted in significantly more clinically relevant information than ...

The genetic counseling for prenatal microarray testing should include a pretest counseling session before the invasive procedure and a post-test counseling session when the results are received.

Microarrays in Prenatal Testing Microarrays have been used in postnatal assessment of the genome since 2004. [16, 17] Shortly thereafter, studies were conducted on the use of microarrays to detect ...

Microarray testing, which uses the same invasive methods as karyotyping — by sampling the chorionic villus cells from the placenta, or amniocentesis, which extracts cells and fetal DNA from ...

Ariosa Diagnostics announced that its scientists have successfully tested and implemented a microarray DNA quantification method for Ariosa's Harmony Non-Invasive Prenatal Test ...

Chromosomal microarray testing in adults with intellectual disability presenting with comorbid psychiatric disorders Kate Wolfe, André Strydom, Deborah Morrogh, Jennifer Carter, Peter Cutajar, Mo ...

A large study from Children's Hospital Boston and the Boston-based Autism Consortium finds that a genetic test that samples the entire genome, known as chromosomal microarray analysis, has about ...

PathogenDx has announced the release of the first quantitative microarray-based test for cannabis, PDx-Quant™, which can determine whether or not a sample exceeds a state or a federal regulatory ...